Last filing: Sep 2, 2026.
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 0 of the 13 calendar months from Oct 2025 to Oct 2026.
- No sale on record before this period.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Jazz Pharmaceuticals plc (JAZZ) | Director | Mar 2, 2026 | Sep 2, 2026 |
| Gilead Sciences (GILD) | Director | Feb 6, 2024 | May 4, 2026 |
| Oruka Therapeutics, Inc. (ORKA) | Former Director | Jun 1, 2004 | Feb 9, 2010 |
Also a director at
Gilead Sciences (GILD), Oruka Therapeutics, Inc. (ORKA) (no filing in the last 18 months)
Recent filings
The last 4 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Aug 31, 2026, Jazz Pharmaceuticals plc: 743 shares withheld by the company for taxes. 1 filing: 1
- Aug 5, 2026, Jazz Pharmaceuticals plc: 1,605 shares granted. 1 filing: 1
- Apr 30, 2026, Gilead Sciences: 1,146 shares granted. 1 filing: 1
- Feb 26, 2026, Jazz Pharmaceuticals plc: 1,527 shares granted. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.